Silica Nanoparticles—A Versatile Tool for the Treatment of Bacterial Infections

by Selvarajan, V., Obuobi, S., Ee, P.L.R.
Published 2021

T-cell death following immune activation is mediated by mitochondria-localized SARM

by Ho, B., Chen, J., Singh, L. P., Selvarajan, V., Ng, S. B., Tan, N. S., Panneerselvam, P., Chng, Wee Joo, Ding, Jeak Ling
Published 2013

T-cell death following immune activation is mediated by mitochondria-localized SARM

by Panneerselvam, P., Singh, L.P., Selvarajan, V., Chng, W.J., Ng, S.B., Tan, N.S., Ho, B., Chen, J., Ding, J.L.
Published 2014

PXR pharmacogenetics: Association of haplotypes with hepatic CYP3A4 and ABCB1 messenger RNA expression and doxorubicin clearance in Asian breast cancer patients

by Sandanaraj, E., Lal, S., Selvarajan, V., Ooi, L.L., Zee, W.W., Nan, S.W., Ang, P.C.S., Lee, E.J.D., Chowbay, B.
Published 2016

Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma

by Ng, S.-B., Yan, J., Huang, G., Selvarajan, V., Tay, J.L.-S., Lin, B., Bi, C., Tan, J., Kwong, Y.-L., Shimizu, N., Aozasa, K., Chng, W.-J.
Published 2014

Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling

by Ng, S.-B., Selvarajan, V., Huang, G., Zhou, J., Feldman, A.L., Law, M., Kwong, Y.-L., Shimizu, N., Kagami, Y., Aozasa, K., Salto-Tellez, M., Chng, W.-J.
Published 2014

RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC

by Selvarajan, V, Osato, M, Nah, GSS, Yan, J, Chung, T-H, Voon, DC-C, Ito, Y, Ham, MF, Salto-Tellez, M, Shimizu, N, Choo, S-N, Fan, S, Chng, W-J, Ng, S-B
Published 2021

Prognostic implication of morphology, cyclinE2 and proliferation in EBV-associated T/NK lymphoproliferative disease in non-immunocompromised hosts

by Ng, S.-B, Ohshima, K, Selvarajan, V, Huang, G, Choo, S.-N, Miyoshi, H, Wang, S, Chua, H.-C, Yeoh, A.E.-J, Quah, T.-C, Koh, L.-P, Tan, P.-L, Chng, W.-J
Published 2020

EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity.

by Yan, J., Ng, S.B., Tay, J.L., Lin, B., Koh, T.L., Tan, J., Selvarajan, V., Liu, S.C., Bi, C., Wang, S., Choo, S.N., Shimizu, N., Huang, G., Yu, Q., Chng, W.J.
Published 2014